The COVID Project
Context, not an orderThis record is guidance or an announcement kept for context. It is not counted among the orders in force.
The record
- Jurisdiction
- U.S. Customs and Border Protection with the Food and Drug Administration; all ports of entry
- Level
- Federal
- Authority
- 21 U.S.C. 381; 19 C.F.R. 141
- Issued
- 2020-03-23 Mar. 23, 2020
- Effective
- 2020-03-23
- End
- not stated (read as 2020-06-30)
- In force
- Mar. 23, 2020 to June 30, 2020
- Quarters
- 2020 Q2
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Other
- Addressees
- importers of FDA-regulated articles
- customs brokers (entry filers)
- consignees
- Functions reached
- SC food, drug, device and cosmetic imports
- OP brokers and importers (paper notices delayed)
- Character
- context
- Collection
- Coast Guard and ports AGY-USCG-PORTS
Operative words
FDA's Import Operations currently remain functional and operational. Activities including FDA Prior Notice review, FDA entry processing, FDA sampling/examination [continue]. While most import operations are not currently experiencing delays, the import community should expect delays in the receipt of hard copy notices.... FDA strongly encourages all members of the import community who deal in FDA-regulated articles to utilize the FDA Import Trade Auxiliary Communication System (ITACS).
Enforcement
21 U.S.C. 381 (refusal of admission) unchanged
Notes
Documents federal import processing under pandemic staffing in March 2020.
Retrieval noteText read in full. the legal effect (if any) lies in the rule, statute or order it announces (e.g., 85 Fed. Reg. 22349 for the duty postponement; 19 U.S.C. 1318). Cite the message as evidence of the operating regime).